CAPZB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.182400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.599200E-03
Normal-vs-Stage2
4.562400E-01
Normal-vs-Stage3
7.105200E-01
Normal-vs-Stage4
9.336800E-01
Stage1-vs-Stage2
1.152760E-01
Stage1-vs-Stage3
4.858400E-01
Stage1-vs-Stage4
3.061900E-02
Stage2-vs-Stage3
9.476400E-01
Stage2-vs-Stage4
3.400200E-01
Stage3-vs-Stage4
6.598000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.056200E-01
Normal-vs-AfricanAmerican
4.265000E-01
Normal-vs-Asian
5.658600E-01
Caucasian-vs-AfricanAmerican
9.694000E-01
Caucasian-vs-Asian
8.816400E-01
AfricanAmerican-vs-Asian
9.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.458000E-01
Normal-vs-Female
5.233000E-01
Male-vs-Female
3.874600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.366820E-01
Normal-vs-Age(41-60Yrs)
6.943600E-01
Normal-vs-Age(61-80Yrs)
3.524600E-01
Normal-vs-Age(81-100Yrs)
1.472220E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.923770E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.049400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.122200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.252200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.980180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.060000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.676200E-01
Normal-vs-Daily Drinker
3.312800E-01
Normal-vs-Weekly Drinker
9.171800E-01
Normal-vs-Occasional Drinker
8.409400E-01
Normal-vs-Social Drinker
2.223800E-01
Non Drinker-vs-Daily Drinker
3.024000E-01
Non Drinker-vs-Weekly Drinker
1.299040E-01
Non Drinker-vs-Occasional Drinker
1.885940E-02
Non Drinker-vs-Social Drinker
3.605400E-01
Daily Drinker-vs-Weekly Drinker
3.515200E-01
Daily Drinker-vs-Occasional Drinker
1.564240E-01
Daily Drinker-vs-Social Drinker
9.579200E-01
Weekly Drinker-vs-Occasional Drinker
9.732200E-01
Weekly Drinker-vs-Social Drinker
3.323800E-01
Occasional Drinker-vs-Social Drinker
1.475220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.709800E-01
Normal-vs-Grade 2
8.812400E-01
Normal-vs-Grade 3
8.402000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.596100E-03
Grade 1-vs-Grade 3
9.244200E-02
Grade 1-vs-Grade 4
7.709800E-01
Grade 2-vs-Grade 3
1.528360E-01
Grade 2-vs-Grade 4
8.812400E-01
Grade 3-vs-Grade 4
8.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.386000E-01
Normal-vs-NonDiabetic
4.436200E-01
Diabetic-vs-NonDiabetic
6.369000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.449800E-01
Normal-vs-NoPancreatitis
4.272800E-01
Pancreatitis-vs-NoPancreatitis
4.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.881000E-01
Normal-vs-N1
4.825400E-01
N0-vs-N1
3.854000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.794200E-01
Normal-vs-TP53-NonMutant
1.014170E-01
TP53-Mutant-vs-TP53-NonMutant
2.036000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
